Director TitleAgeSince
Director/Board Member - 01/10/2010
Director/Board Member - 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
+0.47%+1.95%+23.72%+74.63% 50.05B
-0.81%+0.53%+52.82%+120.17% 40.29B
-0.57%+1.04%+16.65%+87.27% 12.17B
-1.21%+0.20%-10.43%+13.45% 11.96B
+0.57%+1.73%+31.59%+153.11% 9.25B
-0.15%-1.87%+25.21%+46.24% 7.62B
-0.81%+0.55%+27.78%+221.97% 7.36B
-0.34%-0.52%+45.17%-10.98% 7.21B
-0.13%-0.16%-40.47%+15.85% 5.26B
Average +17,989.71%+1.16%+19.12%+80.19% 16.8B
Weighted average by Cap. -0.05%+1.81%+27.75%+87.36%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock